Shares of Stryker Corporation (NYSE:SYK - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the nineteen ratings firms that are covering the company, MarketBeat.com reports. Four research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is $427.30.
A number of equities analysts recently weighed in on the stock. Needham & Company LLC reissued a "buy" rating and issued a $442.00 price target on shares of Stryker in a report on Friday, March 21st. The Goldman Sachs Group set a $422.00 price objective on shares of Stryker in a report on Tuesday, March 4th. Wall Street Zen upgraded Stryker from a "hold" rating to a "buy" rating in a research report on Saturday, June 14th. Roth Mkm upped their price target on Stryker from $405.00 to $456.00 and gave the company a "buy" rating in a research report on Friday, May 2nd. Finally, Sanford C. Bernstein set a $450.00 price target on Stryker in a research report on Monday, May 5th.
Read Our Latest Research Report on Stryker
Insider Activity
In other news, Director Ronda E. Stryker sold 200,000 shares of the stock in a transaction that occurred on Tuesday, May 6th. The stock was sold at an average price of $376.96, for a total transaction of $75,392,000.00. Following the completion of the sale, the director now owns 3,417,326 shares of the company's stock, valued at approximately $1,288,195,208.96. This represents a 5.53% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 5.90% of the company's stock.
Institutional Trading of Stryker
A number of institutional investors and hedge funds have recently added to or reduced their stakes in SYK. Kohmann Bosshard Financial Services LLC purchased a new stake in Stryker in the fourth quarter worth $25,000. Capital A Wealth Management LLC bought a new position in shares of Stryker during the fourth quarter valued at $26,000. Rakuten Securities Inc. increased its holdings in shares of Stryker by 618.2% during the fourth quarter. Rakuten Securities Inc. now owns 79 shares of the medical technology company's stock valued at $28,000 after acquiring an additional 68 shares in the last quarter. Centricity Wealth Management LLC bought a new position in shares of Stryker during the fourth quarter valued at $30,000. Finally, Goodman Advisory Group LLC bought a new position in shares of Stryker during the first quarter valued at $32,000. Hedge funds and other institutional investors own 77.09% of the company's stock.
Stryker Price Performance
SYK opened at $375.44 on Friday. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.64 and a quick ratio of 1.00. The company has a market capitalization of $143.30 billion, a price-to-earnings ratio of 50.73, a P/E/G ratio of 2.83 and a beta of 0.91. The firm's fifty day moving average price is $374.95 and its two-hundred day moving average price is $375.20. Stryker has a 1 year low of $314.93 and a 1 year high of $406.19.
Stryker (NYSE:SYK - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The medical technology company reported $2.84 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.73 by $0.11. The firm had revenue of $5.87 billion for the quarter, compared to the consensus estimate of $5.68 billion. Stryker had a net margin of 12.31% and a return on equity of 23.74%. The business's revenue for the quarter was up 11.9% compared to the same quarter last year. During the same period in the previous year, the firm earned $2.50 EPS. As a group, analysts anticipate that Stryker will post 13.47 earnings per share for the current fiscal year.
Stryker Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Thursday, July 31st. Shareholders of record on Monday, June 30th will be paid a $0.84 dividend. This represents a $3.36 annualized dividend and a yield of 0.89%. The ex-dividend date of this dividend is Monday, June 30th. Stryker's dividend payout ratio is currently 45.41%.
Stryker Company Profile
(
Get Free ReportStryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Stryker, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stryker wasn't on the list.
While Stryker currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.